Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. Children's Cancer Group.
Matthay, K K
Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. Children's Cancer Group. [electronic resource] - The New England journal of medicine Oct 1999 - 1165-73 p. digital
Publication Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
0028-4793
10.1056/NEJM199910143411601 doi
Adolescent
Antineoplastic Combined Chemotherapy Protocols--adverse effects
Bone Marrow Transplantation--adverse effects
Child
Child, Preschool
Combined Modality Therapy
Disease-Free Survival
Humans
Infant
Isotretinoin--adverse effects
Life Tables
Neuroblastoma--drug therapy
Prospective Studies
Risk
Transplantation Conditioning
Whole-Body Irradiation
Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. Children's Cancer Group. [electronic resource] - The New England journal of medicine Oct 1999 - 1165-73 p. digital
Publication Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
0028-4793
10.1056/NEJM199910143411601 doi
Adolescent
Antineoplastic Combined Chemotherapy Protocols--adverse effects
Bone Marrow Transplantation--adverse effects
Child
Child, Preschool
Combined Modality Therapy
Disease-Free Survival
Humans
Infant
Isotretinoin--adverse effects
Life Tables
Neuroblastoma--drug therapy
Prospective Studies
Risk
Transplantation Conditioning
Whole-Body Irradiation